The role of pyruvate kinase M2 in anticancer therapeutic treatments (Review)-Reference-Cited by-同舟云学术

The role of pyruvate kinase M2 in anticancer therapeutic treatments (Review)

Published:2019-10-02 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Su Qiongli¹,Luo Shengping¹,Tan Qiuhong¹,Deng Jun²,Zhou Sichun²,Peng Mei³,Tao Ting⁴,Yang Xiaoping²

Affiliation:

1. Department of Pharmacy, Zhuzhou Central Hospital, Zhuzhou, Hunan 412000, P.R. China

2. Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha, Hunan 410013, P.R. China

3. Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China

4. Department of Pharmacy, Yueyang Maternal‑Child Medicine Health Hospital, Yueyang, Hunan 414000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial signaling pathways and their role in cancer drug resistance;Cellular Signalling;2024-10

2. ETV4/NSUN2 Axis modulates aerobic glycolysis and malignancy in HSCC;Human Molecular Genetics;2024-07-30

3. A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance;Oncogene;2024-05-08

4. Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells – A potential contribution to the predictive, preventive, and personalized medicine;Journal of Advanced Research;2024-01

5. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review;Biomedicine & Pharmacotherapy;2024-01